ID
45727
Descrizione
Principal Investigator: Xin Wei Wang, PhD, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA MeSH: Carcinoma, Hepatocellular,Cholangiocarcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001199 Intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) are clinically disparate primary liver cancers with etiological and biological heterogeneity. We performed targeted sequencing of Thai ICC and HCC among the Thailand Initiative in Genomics and Expression Research for Liver Cancer (TIGER-LC) cohort using the OncoVar platform.
collegamento
Keywords
versioni (1)
- 25/05/23 25/05/23 - Chiara Middel
Titolare del copyright
Xin Wei Wang, PhD, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Caricato su
25 maggio 2023
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs001199 TIGER-LC OncoVar Sequencing
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for liver cancers.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This subject phenotype table contains subject ID, sex, and age at diagnosis.
- This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, histological type [normal, cholangiocarcinoma (CCA), or hepatocellular carcinoma (HCC)], and name of the center which conducted sequencing.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, consent information, subject aliases, and affection status of the subject for liver cancers.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample aliases and sample use.
- This subject phenotype table contains subject ID, sex, and age at diagnosis.
- This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, histological type [normal, cholangiocarcinoma (CCA), or hepatocellular carcinoma (HCC)], and name of the center which conducted sequencing.
C0680251 (UMLS CUI [1,2])
C1551358 (UMLS CUI [1,2])
C1706256 (UMLS CUI [1,3])
C0030705 (UMLS CUI [1,4])
C0521093 (UMLS CUI [1,5])
C0919386 (UMLS CUI [1,6])
C0205225 (UMLS CUI [1,7])
C2239176 (UMLS CUI [1,8])
C0242800 (UMLS CUI [1,9])
C0001779 (UMLS CUI [1,10])
C0680251 (UMLS CUI [2,1])
C0001779 (UMLS CUI [2,2])